Back to Journals » Drug Design, Development and Therapy » Volume 11

Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale

Total article views   Abstract views HTML views PDF downloads Totals
12,583 Dovepress* 7,826 3,024+ 1,540 10,850
PubMed Central* 0 1,733 360 1,733
Totals 7,826 4,757 1,900 12,583
*Since 21 March 2017
+Since July 2016

View citations on PubMed Central and Google Scholar